🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Egypt / NCT05670626
Enrolling by invitation Not applicable

Correlation Between Preoperative Refraction and Anterior Segment Parameters With ICL Vault

NCT05670626 · tracked via the Priya Life Science Egypt tracker
Phase
Not applicable
Started
2022-12-14
Last updated
2025-03-13

Condition(s) studied

Refractive ErrorsMyopiaMyopic Astigmatism

Investigational drug(s) / intervention(s)

Refractive Surgery

Refractive Surgery: Phakic implantable contact lens ( ICL)

Study summary

This prospective non-comparative interventional study aims to analyse the pre-operative factors affecting the range of optimal ICL vaulting. the main question is what is the correlation between age, gender, spherical equivalent, white to white, anterior chamber volume and depth and postoperative vault? participants will do preoperative investigations ( specular microscopy, pentacam and biometry ) then refractive surgery (ICL implantation) followed by follow-up visits to assess the post-operative ICL vault and visual outcome.

Eligibility

Sex
ALL
Min age
21 Years
Max age
45 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Age:21 - 45 years old. * High Myopia or Myopic astigmatism. * Patients with stable preoperative refraction for the previous 12 months. * Aqueous depth (ACD internal) = 2.8 mm or greater from the endothelial side using pentacam. * Patients who are not fit for LASIK. * No previous intraocular surgeries. Exclusion Criteria: * Patients with endothelial cell count \< 2800 cells /mm2 * Patients with corneal opacities * Patients with preoperative glaucoma, cataract, and retinal disease. * Patients with any systemic diseases especially collagen diseases.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Alwatany Eye Hospital Cairo Cairo Governorate

More Kasr El Aini Hospital trials in Egypt

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05670626 on ClinicalTrials.gov ↗ ← All trials in Egypt